Reverse Genetics Systems for the De Novo Rescue of Diverse Members of Paramyxoviridae.
Paramyxoviridae
Paramyxovirus
Reverse genetics
Virus rescue
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
8
12
2023
pubmed:
8
12
2023
entrez:
8
12
2023
Statut:
ppublish
Résumé
Paramyxoviruses place significant burdens on both human and wildlife health; while some paramyxoviruses are established within human populations, others circulate within diverse animal reservoirs. Concerningly, bat-borne paramyxoviruses have spilled over into humans with increasing frequency in recent years, resulting in severe disease. The risk of future zoonotic outbreaks, as well as the persistence of paramyxoviruses that currently circulate within humans, highlights the need for efficient tools through which to interrogate paramyxovirus biology. Reverse genetics systems provide scientists with the ability to rescue paramyxoviruses de novo, offering versatile tools for implementation in both research and public health settings. Reverse genetics systems have greatly improved over the past 30 years, with several key innovations optimizing the success of paramyxovirus rescue. Here, we describe the significance of such advances and provide a generally applicable guide for the development and use of reverse genetics systems for the rescue of diverse members of Paramyxoviridae.
Identifiants
pubmed: 38064024
doi: 10.1007/978-1-0716-3533-9_2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15-35Informations de copyright
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Plemper RK, Lamb RA (2020) Paramyxoviridae: the viruses and their replication. Fields Virol 1(7):504–558
Calain P, Roux L (1993) The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67(8):4822–4830. https://doi.org/10.1128/JVI.67.8.4822-4830.1993
doi: 10.1128/JVI.67.8.4822-4830.1993
pubmed: 8392616
pmcid: 237869
Virtue ER, Marsh GA, Wang L-F (2009) Paramyxoviruses infecting humans: the old, the new and the unknown. Future Microbiol 4(5):537–554. https://doi.org/10.2217/fmb.09.26
doi: 10.2217/fmb.09.26
pubmed: 19492965
Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Cottontail VM, Rasche A, Yordanov S, Seebens A, Knörnschild M, Oppong S, Adu Sarkodie Y, Pongombo C, Lukashev AN, Schmidt-Chanasit J, Stöcker A, Carneiro AJB, Erbar S, Maisner A, Fronhoffs F, Buettner R, Kalko EKV, Kruppa T, Franke CR, Kallies R, Yandoko ERN, Herrler G, Reusken C, Hassanin A, Krüger DH, Matthee S, Ulrich RG, Leroy EM, Drosten C (2012) Bats host major mammalian paramyxoviruses. Nat Commun 3:796. https://doi.org/10.1038/ncomms1796
doi: 10.1038/ncomms1796
pubmed: 22531181
Samal SK (2008) Paramyxoviruses of animals. In: Encyclopedia of virology, p 40
Thibault PA, Watkinson RE, Moreira-Soto A, Drexler JF, Lee B (2017) Zoonotic potential of emerging paramyxoviruses: knowns and unknowns. Adv Virus Res 98:1–55. https://doi.org/10.1016/bs.aivir.2016.12.001
doi: 10.1016/bs.aivir.2016.12.001
pubmed: 28433050
pmcid: 5894875
Amman BR, Albariño CG, Bird BH, Nyakarahuka L, Sealy TK, Balinandi S, Schuh AJ, Campbell SM, Ströher U, Jones MEB, Vodzack ME, Reeder DM, Kaboyo W, Nichol ST, Towner JS (2015) A recently discovered pathogenic paramyxovirus, Sosuga virus, is present in Rousettus aegyptiacus fruit bats at multiple locations in Uganda. J Wildl Dis 51(3):774–779. https://doi.org/10.7589/2015-02-044
doi: 10.7589/2015-02-044
pubmed: 25919464
pmcid: 5022529
Albariño CG, Foltzer M, Towner JS, Rowe LA, Campbell S, Jaramillo CM, Bird BH, Reeder DM, Vodzak ME, Rota P, Metcalfe MG, Spiropoulou CF, Knust B, Vincent JP, Frace MA, Nichol ST, Rollin PE, Ströher U (2014) Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012. Emerg Infect Dis 20(2):211–216. https://doi.org/10.3201/eid2002.131620
doi: 10.3201/eid2002.131620
pubmed: 24447466
Philbey AW, Kirkland PD, Ross AD, Davis RJ, Gleeson AB, Love RJ, Daniels PW, Gould AR, Hyatt AD (1998) An apparently new virus (family Paramyxoviridae) infectious for pigs, humans, and fruit bats. Emerg Infect Dis 4(2):269–271. https://doi.org/10.3201/eid0402.980214
doi: 10.3201/eid0402.980214
pubmed: 9621197
pmcid: 2640116
Eaton BT, Broder CC, Middleton D, Wang L-F (2006) Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 4(1):23–35. https://doi.org/10.1038/nrmicro1323
doi: 10.1038/nrmicro1323
pubmed: 16357858
pmcid: 7097447
Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW (2000) Nipah virus: a recently emergent deadly paramyxovirus. Science 288(5470):1432–1435. https://doi.org/10.1126/science.288.5470.1432
doi: 10.1126/science.288.5470.1432
pubmed: 10827955
Krüger N, Sauder C, Hüttl S, Papies J, Voigt K, Herrler G, Hardes K, Steinmetzer T, Örvell C, Drexler JF, Drosten C, Rubin S, Müller MA, Hoffmann M (2018) Entry, replication, immune evasion, and neurotoxicity of synthetically engineered bat-borne mumps virus. Cell Rep 25(2):312–320.e317. https://doi.org/10.1016/j.celrep.2018.09.018
doi: 10.1016/j.celrep.2018.09.018
pubmed: 30304672
Ikegame S, Carmichael JC, Wells H, Furler O’Brien RL, Acklin JA, Chiu H-P, Oguntuyo KY, Cox RM, Patel AR, Kowdle S, Stevens CS, Eckley M, Zhan S, Lim JK, Veit EC, Evans MJ, Hashiguchi T, Durigon E, Schountz T, Epstein JH, Plemper RK, Daszak P, Anthony SJ, Lee B (2023) Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus. Nat Microbiol 8(6):1108–1122. https://doi.org/10.1038/s41564-023-01380-4
Park KH, Huang T, Correia FF, Krystal M (1991) Rescue of a foreign gene by Sendai virus. Proc Natl Acad Sci U S A 88(13):5537–5541. https://doi.org/10.1073/pnas.88.13.5537
doi: 10.1073/pnas.88.13.5537
pubmed: 1648220
pmcid: 51912
Dimock K, Collins PL (1993) Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3. J Virol 67(5):2772–2778. https://doi.org/10.1128/JVI.67.5.2772-2778.1993
doi: 10.1128/JVI.67.5.2772-2778.1993
pubmed: 8386276
Collins PL, Mink MA, Stec DS (1991) Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc Natl Acad Sci U S A 88(21):9663–9667. https://doi.org/10.1073/pnas.88.21.9663
doi: 10.1073/pnas.88.21.9663
pubmed: 1946383
pmcid: 52778
Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dötsch C, Christiansen G, Billeter MA (1995) Rescue of measles viruses from cloned DNA. EMBO J 14(23):5773–5784
doi: 10.1002/j.1460-2075.1995.tb00266.x
pubmed: 8846771
pmcid: 394696
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (1995) A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 14(24):6087–6094. https://doi.org/10.1002/j.1460-2075.1995.tb00299.x
doi: 10.1002/j.1460-2075.1995.tb00299.x
pubmed: 8557028
pmcid: 394733
Collins PL, Hill MG, Camargo E, Grosfeld H, Chanock RM, Murphy BR (1995) Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci 92(25):11563–11567. https://doi.org/10.1073/pnas.92.25.11563
doi: 10.1073/pnas.92.25.11563
pubmed: 8524804
pmcid: 40442
Borkotoky S, Murali A (2018) The highly efficient T7 RNA polymerase: a wonder macromolecule in biological realm. Int J Biol Macromol 118(Pt A):49–56. https://doi.org/10.1016/j.ijbiomac.2018.05.198
doi: 10.1016/j.ijbiomac.2018.05.198
pubmed: 29847782
Fuerst TR, Earl PL, Moss B (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol Cell Biol 7(7):2538–2544. https://doi.org/10.1128/mcb.7.7.2538-2544.1987
doi: 10.1128/mcb.7.7.2538-2544.1987
pubmed: 3112559
pmcid: 365388
Buchholz UJ, Finke S, Conzelmann K-K (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73(1):251–259. https://doi.org/10.1128/jvi.73.1.251-259.1999
doi: 10.1128/jvi.73.1.251-259.1999
pubmed: 9847328
pmcid: 103829
Beaty SM, Park A, Won ST, Hong P, Lyons M, Vigant F, Freiberg AN, tenOever BR, Duprex WP, Lee B (2017) Efficient and robust paramyxoviridae reverse genetics systems. mSphere 2(2). https://doi.org/10.1128/mSphere.00376-16
Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN (2015) Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. J Virol 89(2):1242–1253. https://doi.org/10.1128/JVI.02583-14
doi: 10.1128/JVI.02583-14
pubmed: 25392218
Li B-Y, Li X-R, Lan X, Yin X-P, Li Z-Y, Yang B, Liu J-X (2011) Rescue of Newcastle disease virus from cloned cDNA using an RNA polymerase II promoter. Arch Virol 156(6):979–986. https://doi.org/10.1007/s00705-011-0932-0
doi: 10.1007/s00705-011-0932-0
pubmed: 21327786
Griffin BD, Leung A, Chan M, Warner BM, Ranadheera C, Tierney K, Audet J, Frost KL, Safronetz D, Embury-Hyatt C, Booth SA, Kobasa D (2019) Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and Bangladesh. Sci Rep 9(1):11171. https://doi.org/10.1038/s41598-019-47549-y
doi: 10.1038/s41598-019-47549-y
pubmed: 31371748
pmcid: 6671980
Chey S, Palmer JM, Doerr L, Liebert UG (2021) Dual promoters improve the rescue of recombinant measles virus in human cells. Viruses 13(9):1723. https://doi.org/10.3390/v13091723
doi: 10.3390/v13091723
pubmed: 34578303
pmcid: 8471996
Martin CT, Muller DK, Coleman JE (1988) Processivity in early stages of transcription by T7 RNA polymerase. Biochemistry 27(11):3966–3974. https://doi.org/10.1021/bi00411a012
doi: 10.1021/bi00411a012
pubmed: 3415967
Kolakofsky D, Pelet T, Garcin D, Hausmann S, Curran J, Roux L (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72(2):891–899. https://doi.org/10.1128/JVI.72.2.891-899.1998
doi: 10.1128/JVI.72.2.891-899.1998
pubmed: 9444980
pmcid: 124558
Egelman EH, Wu SS, Amrein M, Portner A, Murti G (1989) The Sendai virus nucleocapsid exists in at least four different helical states. J Virol 63(5):2233–2243. https://doi.org/10.1128/JVI.63.5.2233-2243.1989
doi: 10.1128/JVI.63.5.2233-2243.1989
pubmed: 2539515
pmcid: 250641
Gutsche I, Desfosses A, Effantin G, Ling WL, Haupt M, Ruigrok RWH, Sachse C, Schoehn G (2015) Structural virology. Near-atomic cryo-EM structure of the helical measles virus nucleocapsid. Science 348(6235):704–707. https://doi.org/10.1126/science.aaa5137
doi: 10.1126/science.aaa5137
pubmed: 25883315
Alayyoubi M, Leser GP, Kors CA, Lamb RA (2015) Structure of the paramyxovirus parainfluenza virus 5 nucleoprotein – RNA complex. Proc Natl Acad Sci 112(14). https://doi.org/10.1073/pnas.1503941112
Ker D-S, Jenkins HT, Greive SJ, Antson AA (2021) CryoEM structure of the Nipah virus nucleocapsid assembly. PLoS Pathog 17(7):e1009740. https://doi.org/10.1371/journal.ppat.1009740
doi: 10.1371/journal.ppat.1009740
pubmed: 34270629
pmcid: 8318291
Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F (2003) A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol 77(21):11546–11554. https://doi.org/10.1128/jvi.77.21.11546-11554.2003
doi: 10.1128/jvi.77.21.11546-11554.2003
pubmed: 14557640
pmcid: 229349
Conzelmann KK (2004) Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 283:1–41. https://doi.org/10.1007/978-3-662-06099-5_1
doi: 10.1007/978-3-662-06099-5_1
pubmed: 15298166
Martin A, Staeheli P, Schneider U (2006) RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication. J Virol 80(12):5708–5715. https://doi.org/10.1128/JVI.02389-05
doi: 10.1128/JVI.02389-05
pubmed: 16731909
pmcid: 1472609
Gassen U, Collins FM, Duprex WP, Rima BK (2000) Establishment of a rescue system for canine distemper virus. J Virol 74(22):10737–10744. https://doi.org/10.1128/jvi.74.22.10737-10744.2000
doi: 10.1128/jvi.74.22.10737-10744.2000
pubmed: 11044118
pmcid: 110948
von Messling V, Springfeld C, Devaux P, Cattaneo R (2003) A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77(23):12579–12591. https://doi.org/10.1128/jvi.77.23.12579-12591.2003
doi: 10.1128/jvi.77.23.12579-12591.2003
Baron MD, Barrett T (1997) Rescue of rinderpest virus from cloned cDNA. J Virol 71(2):1265–1271. https://doi.org/10.1128/JVI.71.2.1265-1271.1997
doi: 10.1128/JVI.71.2.1265-1271.1997
pubmed: 8995650
Hu Q, Chen W, Huang K, Baron MD, Bu Z (2012) Rescue of recombinant peste des petits ruminants virus: creation of a GFP-expressing virus and application in rapid virus neutralization test. Vet Res 43:48. https://doi.org/10.1186/1297-9716-43-48
doi: 10.1186/1297-9716-43-48
pubmed: 22658079
Liu F, Li L, Liu Y, Sun C, Liu C, Wu X, Wang Z (2019) Development of reverse genetics system for small ruminant morbillivirus: rescuing recombinant virus to express Echinococcus granulosus EG95 antigen. Virus Res 261:50–55. https://doi.org/10.1016/j.virusres.2018.12.008
doi: 10.1016/j.virusres.2018.12.008
Liu F, Zhang Y, Li L, Zuo Y, Sun C, Xiaodong W, Wang Z (2019) Rescue of eGFP-expressing small ruminant morbillivirus for identifying susceptibilities of eight mammalian cell lines to its infection. Virus Res 261:60–64. https://doi.org/10.1016/j.virusres.2018.12.011
doi: 10.1016/j.virusres.2018.12.011
pubmed: 30578803
Muniraju M, Mahapatra M, Buczkowski H, Batten C, Banyard AC, Parida S (2015) Rescue of a vaccine strain of peste des petits ruminants virus: in vivo evaluation and comparison with standard vaccine. Vaccine 33(3):465–471. https://doi.org/10.1016/j.vaccine.2014.10.050
doi: 10.1016/j.vaccine.2014.10.050
pubmed: 25444790
pmcid: 4315076
Li Z, Hung C, Paterson RG, Michel F, Fuentes S, Place R, Lin Y, Hogan RJ, Lamb RA, He B (2015) Type II integral membrane protein, TM of J paramyxovirus promotes cell-to-cell fusion. Proc Natl Acad Sci U S A 112(40):12504–12509. https://doi.org/10.1073/pnas.1509476112
doi: 10.1073/pnas.1509476112
pubmed: 26392524
pmcid: 4603449
Engeland CE, Bossow S, Hudacek AW, Hoyler B, Förster J, Veinalde R, Jäger D, Cattaneo R, Ungerechts G, Springfeld C (2017) A Tupaia paramyxovirus vector system for targeting and transgene expression. J Gen Virol 98(9):2248–2257. https://doi.org/10.1099/jgv.0.000887
doi: 10.1099/jgv.0.000887
pubmed: 28809150
Yoneda M, Guillaume V, Ikeda F, Sakuma Y, Sato H, Wild TF, Kai C (2006) Establishment of a Nipah virus rescue system. Proc Natl Acad Sci U S A 103(44):16508–16513. https://doi.org/10.1073/pnas.0606972103
doi: 10.1073/pnas.0606972103
pmcid: 1618306
Lo MK, Peeples ME, Bellini WJ, Nichol ST, Rota PA, Spiropoulou CF (2012) Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response. PLoS One 7(10):e47790. https://doi.org/10.1371/journal.pone.0047790
doi: 10.1371/journal.pone.0047790
pubmed: 23094089
pmcid: 3477106
Marsh GA, Virtue ER, Smith I, Todd S, Arkinstall R, Frazer L, Monaghan P, Smith GA, Broder CC, Middleton D, Wang L-F (2013) Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virol J 10:95. https://doi.org/10.1186/1743-422X-10-95
doi: 10.1186/1743-422X-10-95
pubmed: 23521919
pmcid: 3724489
Laing ED, Amaya M, Navaratnarajah CK et al (2018) Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species. Virology
Newman JT, Surman SR, Riggs JM, Hansen CT, Collins PL, Murphy BR, Skiadopoulos MH (2002) Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics. Virus Genes 24(1):77–92. https://doi.org/10.1023/a:1014042221888
doi: 10.1023/a:1014042221888
pubmed: 11928991
Durbin AP, Hall SL, Siew JW, Whitehead SS, Collins PL, Murphy BR (1997) Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235(2):323–332. https://doi.org/10.1006/viro.1997.8697
doi: 10.1006/viro.1997.8697
pubmed: 9281512
Schmidt AC, McAuliffe JM, Huang A, Surman SR, Bailly JE, Elkins WR, Collins PL, Murphy BR, Skiadopoulos MH (2000) Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J Virol 74(19):8922–8929. https://doi.org/10.1128/jvi.74.19.8922-8929.2000
doi: 10.1128/jvi.74.19.8922-8929.2000
pubmed: 10982335
pmcid: 102087
Hou X, Suquilanda E, Zeledon A, Kacsinta A, Moore A, Seto J, McQueen N (2005) Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin. Med Microbiol Immunol 194(3):129–136. https://doi.org/10.1007/s00430-004-0224-3
doi: 10.1007/s00430-004-0224-3
pubmed: 15834752
Bajimaya S, Hayashi T, Takimoto T (2017) Rescue of Sendai virus from cloned cDNA. Methods Mol Biol 1602:103–110. https://doi.org/10.1007/978-1-4939-6964-7_7
doi: 10.1007/978-1-4939-6964-7_7
pubmed: 28508216
Krishnamurthy S, Huang Z, Samal SK (2000) Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278(1):168–182. https://doi.org/10.1006/viro.2000.0618
doi: 10.1006/viro.2000.0618
pubmed: 11112492
Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A, Villar E, García-Sastre A, Palese P (2001) Recombinant Newcastle disease virus as a vaccine vector. J Virol 75(23):11868–11873. https://doi.org/10.1128/JVI.75.23.11868-11873.2001
doi: 10.1128/JVI.75.23.11868-11873.2001
pubmed: 11689668
pmcid: 114773
Peeters BP, de Leeuw OS, Koch G, Gielkens AL (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73(6):5001–5009. https://doi.org/10.1128/JVI.73.6.5001-5009.1999
doi: 10.1128/JVI.73.6.5001-5009.1999
pubmed: 10233962
pmcid: 112544
Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH 3rd, García-Sastre A, Krammer F, Baric RS, Palese P (2020) Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. EBioMedicine 62:103132. https://doi.org/10.1016/j.ebiom.2020.103132
doi: 10.1016/j.ebiom.2020.103132
pubmed: 33232870
pmcid: 7679520
Elbehairy MA, Khattar SK, Samal SK (2021) Recovery of recombinant avian paramyxovirus type-3 strain wisconsin by reverse genetics and its evaluation as a vaccine vector for chickens. Viruses 13(2). https://doi.org/10.3390/v13020316
Subbiah M, Khattar SK, Collins PL, Samal SK (2011) Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. J Virol 85(11):5394–5405. https://doi.org/10.1128/jvi.02696-10
doi: 10.1128/jvi.02696-10
pubmed: 21450835
pmcid: 3094964
Tsunekuni R, Hikono H, Tanikawa T, Kurata R, Nakaya T, Saito T (2017) Recombinant avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic avian influenza in chickens with antibodies against newcastle disease virus. Avian Dis 61(3):296–306. https://doi.org/10.1637/11512-100616-regr1
doi: 10.1637/11512-100616-regr1
pubmed: 28957006
Xiao S, Khattar SK, Subbiah M, Collins PL, Samal SK (2012) Mutation of the F-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens. J Virol 86(7):3828–3838. https://doi.org/10.1128/jvi.06765-11
doi: 10.1128/jvi.06765-11
pubmed: 22258248
pmcid: 3302521
Clarke DK, Sidhu MS, Johnson JE, Udem SA (2000) Rescue of mumps virus from cDNA. J Virol 74(10):4831–4838. https://doi.org/10.1128/jvi.74.10.4831-4838.2000
doi: 10.1128/jvi.74.10.4831-4838.2000
pubmed: 10775622
pmcid: 112006
Lemon K, Rima BK, McQuaid S, Allen IV, Duprex WP (2007) The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol 81(15):8293–8302. https://doi.org/10.1128/JVI.00266-07
doi: 10.1128/JVI.00266-07
pubmed: 17475640
pmcid: 1951292
Sauder CJ, Zhang CX, Ngo L, Werner K, Lemon K, Duprex WP, Malik T, Carbone K, Rubin SA (2011) Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol 85(14):7059–7069. https://doi.org/10.1128/JVI.00245-11
doi: 10.1128/JVI.00245-11
pubmed: 21543475
pmcid: 3126569
Zhou D, Zhu M-Y, Wang Y-L, Hao X-Q, Zhou D-M, Liu R-X, Zhang C-D, Qu C-F, Zhao Z-Y (2019) Establishment of an efficient reverse genetic system of Mumps virus S79 from cloned DNA. World J Pediatr 15(5):499–505. https://doi.org/10.1007/s12519-019-00286-8
doi: 10.1007/s12519-019-00286-8
pubmed: 31456156
pmcid: 6785654
Kawano M, Kaito M, Kozuka Y, Komada H, Noda N, Nanba K, Tsurudome M, Ito M, Nishio M, Ito Y (2001) Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology 284(1):99–112. https://doi.org/10.1006/viro.2001.0864
doi: 10.1006/viro.2001.0864
pubmed: 11352671
Skiadopoulos MH, Vogel L, Riggs JM, Surman SR, Collins PL, Murphy BR (2003) The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations. J Virol 77(1):270–279. https://doi.org/10.1128/jvi.77.1.270-279.2003
doi: 10.1128/jvi.77.1.270-279.2003
pmcid: 140631
He B, Paterson RG, Ward CD, Lamb RA (1997) Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237(2):249–260. https://doi.org/10.1006/viro.1997.8801
doi: 10.1006/viro.1997.8801
pubmed: 9356337
Parks GD, Ward KR, Rassa JC (2001) Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis. J Virol 75(5):2213–2223. https://doi.org/10.1128/JVI.75.5.2213-2223.2001
doi: 10.1128/JVI.75.5.2213-2223.2001
pubmed: 11160725
pmcid: 114805
Welch SR, Chakrabarti AK, Wiggleton Guerrero L, Jenks HM, Lo MK, Nichol ST, Spiropoulou CF, Albariño CG (2018) Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds. PLoS Negl Trop Dis 12(3):e0006326. https://doi.org/10.1371/journal.pntd.0006326
doi: 10.1371/journal.pntd.0006326
pubmed: 29522528
pmcid: 5862516
Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK (1999) Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73(11):9568–9575. https://doi.org/10.1128/JVI.73.11.9568-9575.1999
doi: 10.1128/JVI.73.11.9568-9575.1999
pubmed: 10516065
pmcid: 112991
Elankumaran S, Rockemann D, Samal SK (2006) Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80(15):7522–7534. https://doi.org/10.1128/JVI.00241-06
doi: 10.1128/JVI.00241-06
pubmed: 16840332
pmcid: 1563725
Reuter JS, Mathews DH (2010) RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinf 11:129. https://doi.org/10.1186/1471-2105-11-129
doi: 10.1186/1471-2105-11-129